drugset / Trial / NCT03736928
Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Glabellar Lines
RandomizedSequentialDouble-blindTreatment
Summary
An interventional phase 2 study to evaluate safety and efficacy of AbobotulinumtoxinA treatment for glabellar lines
Timeline
- Start
- 2018-11-26
- Primary completion
- 2019-12-09
- Completion
- 2020-08-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | — | Intramuscular |
Indications
No indication recorded.